Experienced Leadership

Matthew Nuñez
Chief Executive Officer & Director
Matt Nuñez is the Chief Executive Officer & Director of MorningStar Laboratories with over 25 years of experience in technology entrepreneurship and product development. He specializes in biomarker discovery and has co-founded Liquid Biosciences, focusing on evolutionary computing and bioinformatics. Read More
Nuñez has established a partnership with the University of Pennsylvania’s School of Translational Medicine and developed a pioneering multi-omic biomarker laboratory, making significant contributions in oncology, autoimmune diseases, and companion diagnostics. He holds multiple US patents related to the TNF Class of drugs and has served on various company boards and in C-suite roles, bringing a vast array of expertise to his endeavors.

Lawrence “Larry” Dentice
President, Chief Commercial Officer, & Director
Larry Dentice is the President, Chief Commercial Officer, & Director of MorningStar Laboratories where he oversees the distribution of diagnostic and imaging platforms. With 40 years of experience in the diagnostic imaging field, Dentice has held senior executive roles in engineering, marketing, sales, and business operations. Read More
He has worked for several Fortune 500 companies, including GE Healthcare, where he contributed to the development of CT, MRI, and Nuclear Medicine products, eventually moving into management positions. At Philips Medical Systems, he managed a $4B imaging product portfolio and also served as SVP and General Manager for the $3B medical imaging business at Toshiba America Medical Systems/Canon Medical Systems. Additionally, he was the President of the imaging division at Esaote.
Dentice has held positions on boards for the Radiological Society of North America (RSNA), Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA) and Philips/ De Lage Landen (DLL).

Susie Lu, MPA, CLS
Chief Operating Officer
Susie Lue is the Chief Operating Officer of Morningstar Laboratories, LLC. She has extensive experience in executive roles such as CEO and COO and has managed complex diagnostic and ambulatory operations for various healthcare organizations including Columbia HCA Hospitals, UCSF, Stanford, and UCLA Health System. Read More
She has also provided consulting services for healthcare system operations at the University of Colorado Health System, Adventist Hospitals in California and Florida, and primary healthcare systems in Vietnam and China.

Tina Senter
Chief Financial Officer
Tina Senter is the Chief Financial Officer of MorningStar Laboratories with over 15 years of experience in full-scope accounting. Her expertise includes budget forecasting, financial reporting, and variance analysis. Previously, she held key roles as Controller at PFD Management and PP Web Pros, Interim Controller at Predictive Health Diagnostics, and Senior Accountant at SingerLeWak LLP. Read More
Senter excels in team leadership, consolidations, and intercompany transactions, and is dedicated to delivering excellence in accounting and financial management.